×

Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer

  • US 10,316,038 B2
  • Filed: 01/25/2018
  • Issued: 06/11/2019
  • Est. Priority Date: 01/25/2017
  • Status: Active Grant
First Claim
Patent Images

1. A compound, of Formula (I):

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×